Isoquinoline and quinazoline urea analogues as antagonists for the human adenosine A3 receptor

被引:117
作者
van Muijlwijk-Koezen, JE [1 ]
Timmerman, H [1 ]
van der Goot, H [1 ]
Menge, WMPB [1 ]
Künzel, JFV [1 ]
de Groote, M [1 ]
IJzerman, AP [1 ]
机构
[1] Free Univ Amsterdam, Dept Pharmacochem, Div Med Chem, Leiden Amsterdam Ctr Drug Res, NL-1081 HV Amsterdam, Netherlands
关键词
D O I
10.1021/jm000002u
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Isoquinoline and quinazoline urea derivatives were found to bind to human adenosine A(3) receptors. Series of N-phenyl-N'-quinazolin-4-ylurea derivatives and N-phenyl-N'-isoquinolin-1-ylurea derivatives were synthesized and tested in radioligand binding assays on their adenosine receptor affinities. A structure-affinity analysis indicated that on the 2-position of the quinazoline ring or the equivalent 3-position of the isoquinoline ring a phenyl or heteroaryl substituent increased the adenosine A(3) receptor affinity in comparison to unsubstituted or aliphatic derivatives. Furthermore, the structure-affinity relationship of substituted phenylurea analogues was investigated. Substituents such as electron-withdrawing or electron-donating groups were introduced at different positions of the benzene ring to probe electronic and positional effects of substitution. Substitution on the 3- or 4-position of the phenyl ring decreased the adenosine A(3) receptor affinity. Substitution at position 2 with an electron-donating substituent, such as methyl qr methoxy, increased human adenosine A(3) receptor affinity, whereas substitution on the 2-position with an electron withdrawing -substituent did not influence affinity. Combination of the optimal substituents in the two series had an additive effect; which led to the potent human adenosine A(3) receptor antagonist N-(2-methoxyphenyl)-N'-(2-(3-pyridyl)quinazolin-4-yl)urea (VUF5574, 10a) showing a K-i value of 4 nM and being at least 2500-fold selective vs A(1) and A(2A) receptors. Compound 10a competitively antagonized the effect of an agonist in a functional A3 receptor assay, i.e., inhibition of cAMP production in cells expressing the human adenosine A3 receptor; a pA(2) value of 8.1 was derived from a Schild plot. In conclusion, compound 10a is a potent and selective human adenosine A(3) receptor antagonist and might be a useful tool in further characterization of the human A(3) receptor.
引用
收藏
页码:2227 / 2238
页数:12
相关论文
共 35 条
[1]   Novel N-6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A(3) adenosine receptors [J].
Baraldi, PG ;
Cacciari, B ;
Spalluto, G ;
Ji, XD ;
Olah, ME ;
Stiles, G ;
Dionisotti, S ;
Zocchi, C ;
Ongini, E ;
Jacobson, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (03) :802-806
[2]  
BEAVEN MA, 1994, TRENDS PHARMACOL SCI, V15, P13, DOI 10.1016/0165-6147(94)90124-4
[3]  
Bouma MG, 1997, J IMMUNOL, V158, P5400
[4]   Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors .2. Synthesis and further structure-activity relationship studies of PETT analogs [J].
Cantrell, AS ;
Engelhardt, P ;
Hogberg, M ;
Jaskunas, SR ;
Johansson, NG ;
Jordan, CL ;
Kangasmetsa, J ;
Kinnick, MD ;
Lind, P ;
Morin, JM ;
Muesing, MA ;
Noreen, R ;
Oberg, B ;
Pranc, P ;
Sahlberg, C ;
Ternansky, RJ ;
Vasileff, RT ;
Vrang, L ;
West, SJ ;
Zhang, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (21) :4261-4274
[5]   REARRANGEMENT OF 3-AMINO-1-BENZYLINDAZOLE TO 4-AMINO-2-PHENYLQUINAZOLINE [J].
FINCH, N ;
GSCHWEND, HW .
JOURNAL OF ORGANIC CHEMISTRY, 1971, 36 (11) :1463-&
[6]  
JACOBSON MA, 1996, DRUG DEVELOP RES, V37, P131
[7]  
JACOBSON MA, 1998, Patent No. 5780481
[8]  
Jacobson Marlene A., 1997, P315
[9]  
JARVIS MF, 1989, J PHARMACOL EXP THER, V251, P888
[10]   6-phenyl-1,4-dihydropyridine derivatives as potent and selective A(3) adenosine receptor antagonists [J].
Jiang, JL ;
vanRhee, AM ;
Melman, N ;
Ji, XD ;
Jacobson, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (23) :4667-4675